Gruninger Marcinsider trades

In SEC Form 4 filings, Gruninger Marc is listed as Director of Veraxa Biotech AG - Post de-SPAC (VRXA). In the last 90 days, Gruninger Marc bought $10K of Veraxa Biotech AG - Post de-SPAC (VRXA) on the open market and sold none. The largest purchase was $9.1K of Veraxa Biotech AG - Post de-SPAC (VRXA) on Oct 28. Took part in a cluster buy; the latest at Veraxa Biotech AG - Post de-SPAC (VRXA), where 2 insiders bought within 9 days, ending Oct 28.

Companies and roles

Company	Role	Transactions	Last filed
VRXAVeraxa Biotech AG - Post de-SPAC	Director	2	Oct 29

Cluster buys

VRXA: 2 insiders bought $42.7K between Oct 20 – Oct 28.

Form 4 historysince 2026-10-29

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
VRXAVeraxa Biotech AG - Post de-SPAC	Oct 28	Oct 29	P	9,133	$1.00	Purchase +$9,133	10,000	No	Form 4
VRXAVeraxa Biotech AG - Post de-SPAC	Oct 27	Oct 29	P	867	$0.98	Purchase +$850	867	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.